ID   AROA_ECOLI              Reviewed;         427 AA.
AC   P0A6D3; P07638; P78222;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2005, sequence version 1.
DT   15-MAR-2017, entry version 105.
DE   RecName: Full=3-phosphoshikimate 1-carboxyvinyltransferase {ECO:0000255|HAMAP-Rule:MF_00210};
DE            EC=2.5.1.19 {ECO:0000255|HAMAP-Rule:MF_00210, ECO:0000269|PubMed:12430021, ECO:0000269|PubMed:13129913, ECO:0000269|PubMed:16225867, ECO:0000269|PubMed:17855366, ECO:0000269|PubMed:19211556, ECO:0000269|PubMed:6229418};
DE   AltName: Full=5-enolpyruvylshikimate-3-phosphate synthase {ECO:0000255|HAMAP-Rule:MF_00210, ECO:0000303|Ref.1};
DE            Short=EPSP synthase {ECO:0000255|HAMAP-Rule:MF_00210, ECO:0000303|Ref.1};
DE            Short=EPSPS {ECO:0000255|HAMAP-Rule:MF_00210, ECO:0000305};
GN   Name=aroA {ECO:0000255|HAMAP-Rule:MF_00210, ECO:0000303|Ref.1};
GN   OrderedLocusNames=b0908, JW0891;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Duncan K., Lewendon A., Coggins J.R.;
RT   "The complete amino acid sequence of Escherichia coli 5-
RT   enolpyruvylshikimate 3-phosphate synthase.";
RL   FEBS Lett. 170:59-63(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=8905232; DOI=10.1093/dnares/3.3.137;
RA   Oshima T., Aiba H., Baba T., Fujita K., Hayashi K., Honjo A.,
RA   Ikemoto K., Inada T., Itoh T., Kajihara M., Kanai K., Kashimoto K.,
RA   Kimura S., Kitagawa M., Makino K., Masuda S., Miki T., Mizobuchi K.,
RA   Mori H., Motomura K., Nakamura Y., Nashimoto H., Nishio Y., Saito N.,
RA   Sampei G., Seki Y., Tagami H., Takemoto K., Wada C., Yamamoto Y.,
RA   Yano M., Horiuchi T.;
RT   "A 718-kb DNA sequence of the Escherichia coli K-12 genome
RT   corresponding to the 12.7-28.0 min region on the linkage map.";
RL   DNA Res. 3:137-155(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 380-427.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RA   Palma C.A., Allen E., Araujo R., Aparicio A.M., Botstein D.,
RA   Cherry M., Chung E., Dietrich F., Duncan M., Federspiel N., Kalman S.,
RA   Kim K., Komp C., Lashkari D., Lew H., Lin D., Namath A., Oefner P.,
RA   Davis R.;
RL   Submitted (JUL-1995) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME
RP   REGULATION, AND SUBUNIT.
RX   PubMed=6229418; DOI=10.1016/0014-5793(84)80027-7;
RA   Duncan K., Lewendon A., Coggins J.R.;
RT   "The purification of 5-enolpyruvylshikimate 3-phosphate synthase from
RT   an overproducing strain of Escherichia coli.";
RL   FEBS Lett. 165:121-127(1984).
RN   [7]
RP   ENZYME REGULATION.
RX   PubMed=1899181; DOI=10.1016/0003-9861(91)90316-B;
RA   Huynh Q.K.;
RT   "5-enolpyruvylshikimate-3-phosphate synthase from Escherichia coli --
RT   the substrate analogue bromopyruvate inactivates the enzyme by
RT   modifying Cys-408 and Lys-411.";
RL   Arch. Biochem. Biophys. 284:407-412(1991).
RN   [8]
RP   PHOTO-OXIDATION AT HIS-385.
RX   PubMed=8452542; DOI=10.1042/bj2900525;
RA   Huynh Q.K.;
RT   "Photo-oxidation of 5-enolpyruvoylshikimate-3-phosphate synthase from
RT   Escherichia coli: evidence for a reactive imidazole group (His385) at
RT   the herbicide glyphosate-binding site.";
RL   Biochem. J. 290:525-530(1993).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
RX   PubMed=11607190; DOI=10.1073/pnas.88.11.5046;
RA   Stallings W.C., Abdel-Meguid S.S., Lim L.W., Shieh H.-S.,
RA   Dayringer H.E., Leimgruber N.K., Stegeman R.A., Anderson K.S.,
RA   Sikorski J.A., Padgette S.R., Kishore G.M.;
RT   "Structure and topological symmetry of the glyphosate target 5-enol-
RT   pyruvylshikimate-3-phosphate synthase: a distinctive protein fold.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:5046-5050(1991).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) IN COMPLEX WITH
RP   SHIKIMATE-3-PHOSPHATE AND PHOSPHOENOLPYRUVATE ANALOG.
RX   PubMed=11171958; DOI=10.1073/pnas.98.4.1376;
RA   Schonbrunn E., Eschenburg S., Shuttleworth W.A., Schloss J.V.,
RA   Amrhein N., Evans J.N., Kabsch W.;
RT   "Interaction of the herbicide glyphosate with its target enzyme 5-
RT   enolpyruvylshikimate 3-phosphate synthase in atomic detail.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:1376-1380(2001).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF MUTANT ALA-96 IN COMPLEX
RP   WITH SHIKIMATE-3-PHOSPHATE, FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS
RP   OF GLY-96, BIOPHYSICOCHEMICAL PROPERTIES, AND ENZYME REGULATION.
RX   PubMed=12430021; DOI=10.1007/s00425-002-0908-0;
RA   Eschenburg S., Healy M.L., Priestman M.A., Lushington G.H.,
RA   Schonbrunn E.;
RT   "How the mutation glycine96 to alanine confers glyphosate
RT   insensitivity to 5-enolpyruvyl shikimate-3-phosphate synthase from
RT   Escherichia coli.";
RL   Planta 216:129-135(2002).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF MUTANT ALA-313 IN COMPLEX
RP   WITH SHIKIMATE-3-PHOSPHATE ANALOG, FUNCTION, CATALYTIC ACTIVITY,
RP   MUTAGENESIS OF ASP-313, ACTIVE SITE, AND REACTION MECHANISM.
RX   PubMed=13129913; DOI=10.1074/jbc.M309741200;
RA   Eschenburg S., Kabsch W., Healy M.L., Schonbrunn E.;
RT   "A new view of the mechanisms of UDP-N-acetylglucosamine enolpyruvyl
RT   transferase (MurA) and 5-enolpyruvylshikimate-3-phosphate synthase
RT   (AroA) derived from X-ray structures of their tetrahedral reaction
RT   intermediate states.";
RL   J. Biol. Chem. 278:49215-49222(2003).
RN   [13]
RP   STRUCTURE BY NMR OF 25-240.
RA   Young J.K., Stauffer M.E., Kim H.J., Helms G.L., Evans J.N.S.;
RT   "Letter: Substrate-induced structural changes to the isolated N-
RT   terminal domain of 5-enolpyruvylshikimate-3-phosphate synthase.";
RL   Submitted (MAY-2003) to the PDB data bank.
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) IN COMPLEX WITH
RP   SHIKIMATE-3-PHOSPHATE ANALOGS, ENZYME REGULATION, ACTIVE SITE, AND
RP   REACTION MECHANISM.
RX   PubMed=15736934; DOI=10.1021/bi048198d;
RA   Priestman M.A., Healy M.L., Becker A., Alberg D.G., Bartlett P.A.,
RA   Lushington G.H., Schonbrunn E.;
RT   "Interaction of phosphonate analogues of the tetrahedral reaction
RT   intermediate with 5-enolpyruvylshikimate-3-phosphate synthase in
RT   atomic detail.";
RL   Biochemistry 44:3241-3248(2005).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) IN COMPLEX WITH
RP   SHIKIMATE-3-PHOSPHATE AND PHOSPHOENOLPYRUVATE ANALOGS, FUNCTION,
RP   CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16225867; DOI=10.1016/j.febslet.2005.09.066;
RA   Priestman M.A., Healy M.L., Funke T., Becker A., Schonbrunn E.;
RT   "Molecular basis for the glyphosate-insensitivity of the reaction of
RT   5-enolpyruvylshikimate 3-phosphate synthase with shikimate.";
RL   FEBS Lett. 579:5773-5780(2005).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) IN COMPLEX WITH
RP   SHIKIMATE-3-PHOSPHATE ANALOGS, FUNCTION, ACTIVE SITE, AND ENZYME
RP   REGULATION.
RX   PubMed=17958399; DOI=10.1021/bi701095u;
RA   Funke T., Healy-Fried M.L., Han H., Alberg D.G., Bartlett P.A.,
RA   Schonbrunn E.;
RT   "Differential inhibition of class I and class II 5-
RT   enolpyruvylshikimate-3-phosphate synthases by tetrahedral reaction
RT   intermediate analogues.";
RL   Biochemistry 46:13344-13351(2007).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF MUTANTS L101 AND S101 IN
RP   COMPLEX WITH SHIKIMATE-3-PHOSPHATE AND PHOSPHOENOLPYRUVATE ANALOGS,
RP   FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF PRO-101, ACTIVE SITE, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=17855366; DOI=10.1074/jbc.M705624200;
RA   Healy-Fried M.L., Funke T., Priestman M.A., Han H., Schonbrunn E.;
RT   "Structural basis of glyphosate tolerance resulting from mutations of
RT   Pro101 in Escherichia coli 5-enolpyruvylshikimate-3-phosphate
RT   synthase.";
RL   J. Biol. Chem. 282:32949-32955(2007).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) IN COMPLEX WITH
RP   SHIKIMATE-3-PHOSPHATE AND PHOSPHOENOLPYRUVATE ANALOGS, FUNCTION,
RP   CATALYTIC ACTIVITY, MUTAGENESIS OF THR-97 AND PRO-101, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=19211556; DOI=10.1074/jbc.M809771200;
RA   Funke T., Yang Y., Han H., Healy-Fried M., Olesen S., Becker A.,
RA   Schonbrunn E.;
RT   "Structural basis of glyphosate resistance resulting from the double
RT   mutation Thr97 -> Ile and Pro101 -> Ser in 5-enolpyruvylshikimate-3-
RT   phosphate synthase from Escherichia coli.";
RL   J. Biol. Chem. 284:9854-9860(2009).
CC   -!- FUNCTION: Catalyzes the transfer of the enolpyruvyl moiety of
CC       phosphoenolpyruvate (PEP) to the 5-hydroxyl of shikimate-3-
CC       phosphate (S3P) to produce enolpyruvyl shikimate-3-phosphate and
CC       inorganic phosphate. {ECO:0000255|HAMAP-Rule:MF_00210,
CC       ECO:0000269|PubMed:12430021, ECO:0000269|PubMed:13129913,
CC       ECO:0000269|PubMed:16225867, ECO:0000269|PubMed:17855366,
CC       ECO:0000269|PubMed:17958399, ECO:0000269|PubMed:19211556,
CC       ECO:0000269|PubMed:6229418}.
CC   -!- CATALYTIC ACTIVITY: Phosphoenolpyruvate + 3-phosphoshikimate =
CC       phosphate + 5-O-(1-carboxyvinyl)-3-phosphoshikimate.
CC       {ECO:0000255|HAMAP-Rule:MF_00210, ECO:0000269|PubMed:12430021,
CC       ECO:0000269|PubMed:13129913, ECO:0000269|PubMed:16225867,
CC       ECO:0000269|PubMed:17855366, ECO:0000269|PubMed:17958399,
CC       ECO:0000269|PubMed:19211556, ECO:0000269|PubMed:6229418}.
CC   -!- ENZYME REGULATION: Competitively inhibited by glyphosate
CC       (PubMed:12430021, PubMed:6229418). Inhibited by (S)- and (R)-
CC       phosphonates analogs (PubMed:15736934). Inhibited by (R)-
CC       difluoromethyl analogs of the tetrahedral reaction intermediate
CC       (PubMed:16225867). Inhibited by bromopyruvate (PubMed:1899181).
CC       {ECO:0000269|PubMed:12430021, ECO:0000269|PubMed:15736934,
CC       ECO:0000269|PubMed:16225867, ECO:0000269|PubMed:17958399,
CC       ECO:0000269|PubMed:1899181, ECO:0000269|PubMed:6229418}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.0035 mM for S3P (at pH 7 and 25 degrees Celsius
CC         {ECO:0000269|PubMed:6229418};
CC         KM=0.015 mM for PEP (at pH 7 and 25 degrees Celsius
CC         {ECO:0000269|PubMed:6229418};
CC         KM=0.045 mM for PEP (at pH 7.5 and 25 degrees Celsius
CC         {ECO:0000269|PubMed:19211556};
CC         KM=0.048 mM for S3P (at pH 7.5 and 25 degrees Celsius
CC         {ECO:0000269|PubMed:19211556};
CC         KM=0.06 mM for PEP (at pH 7.5 and 25 degrees Celsius
CC         {ECO:0000269|PubMed:17855366};
CC         KM=0.06 mM for S3P (at pH 7.5 and 25 degrees Celsius
CC         {ECO:0000269|PubMed:17855366};
CC         KM=0.088 mM for PEP (at pH 6.8 and 20 degrees Celsius
CC         {ECO:0000269|PubMed:12430021};
CC         KM=0.09 mM for S3P (at pH 5.5 and 20 degrees Celsius
CC         {ECO:0000269|PubMed:16225867};
CC         KM=0.1 mM for PEP (at pH 5.5 and 20 degrees Celsius
CC         {ECO:0000269|PubMed:16225867};
CC         KM=0.12 mM for S3P (at pH 6.8 and 20 degrees Celsius
CC         {ECO:0000269|PubMed:12430021};
CC         Vmax=50 umol/min/ug enzyme (at pH 7.5 and 25 degrees Celsius
CC         {ECO:0000269|PubMed:17855366};
CC         Vmax=53 umol/min/ug enzyme (at pH 5.5 and 20 degrees Celsius
CC         {ECO:0000269|PubMed:16225867};
CC         Vmax=57 umol/min/ug enzyme (at pH 7.5 and 25 degrees Celsius
CC         {ECO:0000269|PubMed:19211556};
CC       pH dependence:
CC         Optimum pH is between 6 and 6.5. {ECO:0000269|PubMed:12430021,
CC         ECO:0000269|PubMed:16225867, ECO:0000269|PubMed:17855366,
CC         ECO:0000269|PubMed:19211556, ECO:0000269|PubMed:6229418};
CC   -!- PATHWAY: Metabolic intermediate biosynthesis; chorismate
CC       biosynthesis; chorismate from D-erythrose 4-phosphate and
CC       phosphoenolpyruvate: step 6/7. {ECO:0000255|HAMAP-Rule:MF_00210,
CC       ECO:0000305}.
CC   -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_00210,
CC       ECO:0000269|PubMed:6229418}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00210,
CC       ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the EPSP synthase family.
CC       {ECO:0000255|HAMAP-Rule:MF_00210, ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X00557; CAA25223.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC73994.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA35643.1; -; Genomic_DNA.
DR   EMBL; U31523; AAA81514.1; -; Genomic_DNA.
DR   PIR; C64830; XUECVS.
DR   RefSeq; NP_415428.1; NC_000913.3.
DR   RefSeq; WP_000445231.1; NZ_LN832404.1.
DR   PDB; 1EPS; X-ray; 3.00 A; A=1-427.
DR   PDB; 1G6S; X-ray; 1.50 A; A=1-427.
DR   PDB; 1G6T; X-ray; 1.60 A; A=1-427.
DR   PDB; 1MI4; X-ray; 1.70 A; A=1-427.
DR   PDB; 1P88; NMR; -; A=25-240.
DR   PDB; 1P89; NMR; -; A=25-240.
DR   PDB; 1Q0I; Model; -; A=1-427.
DR   PDB; 1Q0J; Model; -; A=1-427.
DR   PDB; 1Q36; X-ray; 1.60 A; A=1-427.
DR   PDB; 1X8R; X-ray; 1.50 A; A=1-427.
DR   PDB; 1X8T; X-ray; 1.90 A; A=1-427.
DR   PDB; 2AA9; X-ray; 1.50 A; A=1-427.
DR   PDB; 2AAY; X-ray; 1.55 A; A=1-427.
DR   PDB; 2PQ9; X-ray; 1.60 A; A=1-427.
DR   PDB; 2QFQ; X-ray; 1.50 A; A=1-427.
DR   PDB; 2QFS; X-ray; 1.55 A; A=1-427.
DR   PDB; 2QFT; X-ray; 1.55 A; A=1-427.
DR   PDB; 2QFU; X-ray; 1.60 A; A=1-427.
DR   PDB; 3FJX; X-ray; 1.75 A; A=1-427.
DR   PDB; 3FJZ; X-ray; 1.70 A; A=1-427.
DR   PDB; 3FK0; X-ray; 1.70 A; A=1-427.
DR   PDB; 3FK1; X-ray; 1.70 A; A=1-427.
DR   PDBsum; 1EPS; -.
DR   PDBsum; 1G6S; -.
DR   PDBsum; 1G6T; -.
DR   PDBsum; 1MI4; -.
DR   PDBsum; 1P88; -.
DR   PDBsum; 1P89; -.
DR   PDBsum; 1Q0I; -.
DR   PDBsum; 1Q0J; -.
DR   PDBsum; 1Q36; -.
DR   PDBsum; 1X8R; -.
DR   PDBsum; 1X8T; -.
DR   PDBsum; 2AA9; -.
DR   PDBsum; 2AAY; -.
DR   PDBsum; 2PQ9; -.
DR   PDBsum; 2QFQ; -.
DR   PDBsum; 2QFS; -.
DR   PDBsum; 2QFT; -.
DR   PDBsum; 2QFU; -.
DR   PDBsum; 3FJX; -.
DR   PDBsum; 3FJZ; -.
DR   PDBsum; 3FK0; -.
DR   PDBsum; 3FK1; -.
DR   ProteinModelPortal; P0A6D3; -.
DR   SMR; P0A6D3; -.
DR   BioGrid; 4260011; 10.
DR   DIP; DIP-48256N; -.
DR   IntAct; P0A6D3; 3.
DR   STRING; 511145.b0908; -.
DR   BindingDB; P0A6D3; -.
DR   ChEMBL; CHEMBL5033; -.
DR   DrugBank; DB03116; 5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate.
DR   DrugBank; DB01942; Formic Acid.
DR   DrugBank; DB04539; Glyphosate.
DR   DrugBank; DB04328; Shikimate-3-Phosphate.
DR   SWISS-2DPAGE; P0A6D3; -.
DR   EPD; P0A6D3; -.
DR   PaxDb; P0A6D3; -.
DR   PRIDE; P0A6D3; -.
DR   EnsemblBacteria; AAC73994; AAC73994; b0908.
DR   EnsemblBacteria; BAA35643; BAA35643; BAA35643.
DR   GeneID; 945528; -.
DR   KEGG; ecj:JW0891; -.
DR   KEGG; eco:b0908; -.
DR   PATRIC; 32117029; VBIEscCol129921_0939.
DR   EchoBASE; EB0071; -.
DR   EcoGene; EG10073; aroA.
DR   eggNOG; ENOG4105CMY; Bacteria.
DR   eggNOG; COG0128; LUCA.
DR   HOGENOM; HOG000247372; -.
DR   InParanoid; P0A6D3; -.
DR   KO; K00800; -.
DR   OMA; ETDHRVA; -.
DR   PhylomeDB; P0A6D3; -.
DR   BioCyc; EcoCyc:AROA-MONOMER; -.
DR   BioCyc; MetaCyc:AROA-MONOMER; -.
DR   BRENDA; 2.5.1.19; 2026.
DR   SABIO-RK; P0A6D3; -.
DR   UniPathway; UPA00053; UER00089.
DR   EvolutionaryTrace; P0A6D3; -.
DR   PRO; PR:P0A6D3; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0003866; F:3-phosphoshikimate 1-carboxyvinyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0009073; P:aromatic amino acid family biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0009423; P:chorismate biosynthetic process; IDA:EcoCyc.
DR   Gene3D; 3.65.10.10; -; 2.
DR   HAMAP; MF_00210; EPSP_synth; 1.
DR   InterPro; IPR001986; Enolpyruvate_Tfrase_dom.
DR   InterPro; IPR006264; EPSP_synthase.
DR   InterPro; IPR023193; EPSP_synthase_CS.
DR   InterPro; IPR013792; RNA3'P_cycl/enolpyr_Trfase_a/b.
DR   Pfam; PF00275; EPSP_synthase; 1.
DR   PIRSF; PIRSF000505; EPSPS; 1.
DR   SUPFAM; SSF55205; SSF55205; 1.
DR   TIGRFAMs; TIGR01356; aroA; 1.
DR   PROSITE; PS00104; EPSP_SYNTHASE_1; 1.
DR   PROSITE; PS00885; EPSP_SYNTHASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Amino-acid biosynthesis;
KW   Aromatic amino acid biosynthesis; Complete proteome; Cytoplasm;
KW   Reference proteome; Transferase.
FT   CHAIN         1    427       3-phosphoshikimate 1-
FT                                carboxyvinyltransferase.
FT                                /FTId=PRO_0000088253.
FT   REGION       22     23       Shikimate-3-phosphate binding.
FT                                {ECO:0000255|HAMAP-Rule:MF_00210,
FT                                ECO:0000269|PubMed:11171958,
FT                                ECO:0000269|PubMed:12430021,
FT                                ECO:0000269|PubMed:13129913,
FT                                ECO:0000269|PubMed:15736934,
FT                                ECO:0000269|PubMed:16225867,
FT                                ECO:0000269|PubMed:17855366,
FT                                ECO:0000269|PubMed:17958399,
FT                                ECO:0000269|PubMed:19211556}.
FT   REGION       94     97       Phosphoenolpyruvate. {ECO:0000255|HAMAP-
FT                                Rule:MF_00210,
FT                                ECO:0000269|PubMed:11171958,
FT                                ECO:0000269|PubMed:16225867,
FT                                ECO:0000269|PubMed:17855366,
FT                                ECO:0000269|PubMed:19211556}.
FT   REGION      169    171       Shikimate-3-phosphate binding.
FT                                {ECO:0000255|HAMAP-Rule:MF_00210,
FT                                ECO:0000269|PubMed:11171958,
FT                                ECO:0000269|PubMed:12430021,
FT                                ECO:0000269|PubMed:13129913,
FT                                ECO:0000269|PubMed:15736934,
FT                                ECO:0000269|PubMed:16225867,
FT                                ECO:0000269|PubMed:17855366,
FT                                ECO:0000269|PubMed:17958399,
FT                                ECO:0000269|PubMed:19211556}.
FT   ACT_SITE    313    313       Proton acceptor. {ECO:0000255|HAMAP-
FT                                Rule:MF_00210,
FT                                ECO:0000269|PubMed:11171958,
FT                                ECO:0000269|PubMed:12430021,
FT                                ECO:0000269|PubMed:15736934,
FT                                ECO:0000269|PubMed:16225867,
FT                                ECO:0000269|PubMed:17855366,
FT                                ECO:0000269|PubMed:17958399,
FT                                ECO:0000269|PubMed:19211556}.
FT   ACT_SITE    341    341       Proton donor. {ECO:0000255|HAMAP-
FT                                Rule:MF_00210,
FT                                ECO:0000269|PubMed:15736934,
FT                                ECO:0000305|PubMed:11171958}.
FT   BINDING      27     27       Shikimate-3-phosphate.
FT                                {ECO:0000255|HAMAP-Rule:MF_00210,
FT                                ECO:0000269|PubMed:11171958,
FT                                ECO:0000269|PubMed:12430021,
FT                                ECO:0000269|PubMed:13129913,
FT                                ECO:0000269|PubMed:15736934,
FT                                ECO:0000269|PubMed:17855366,
FT                                ECO:0000269|PubMed:17958399,
FT                                ECO:0000269|PubMed:19211556}.
FT   BINDING     124    124       Phosphoenolpyruvate. {ECO:0000255|HAMAP-
FT                                Rule:MF_00210,
FT                                ECO:0000269|PubMed:11171958,
FT                                ECO:0000269|PubMed:16225867,
FT                                ECO:0000269|PubMed:17855366,
FT                                ECO:0000269|PubMed:19211556}.
FT   BINDING     197    197       Shikimate-3-phosphate.
FT                                {ECO:0000255|HAMAP-Rule:MF_00210,
FT                                ECO:0000269|PubMed:11171958,
FT                                ECO:0000269|PubMed:12430021,
FT                                ECO:0000269|PubMed:13129913,
FT                                ECO:0000269|PubMed:15736934,
FT                                ECO:0000269|PubMed:17855366,
FT                                ECO:0000269|PubMed:17958399,
FT                                ECO:0000269|PubMed:19211556}.
FT   BINDING     336    336       Shikimate-3-phosphate.
FT                                {ECO:0000255|HAMAP-Rule:MF_00210,
FT                                ECO:0000269|PubMed:11171958,
FT                                ECO:0000269|PubMed:12430021,
FT                                ECO:0000269|PubMed:13129913,
FT                                ECO:0000269|PubMed:15736934,
FT                                ECO:0000269|PubMed:17855366,
FT                                ECO:0000269|PubMed:17958399,
FT                                ECO:0000269|PubMed:19211556}.
FT   BINDING     340    340       Shikimate-3-phosphate.
FT                                {ECO:0000255|HAMAP-Rule:MF_00210,
FT                                ECO:0000269|PubMed:11171958,
FT                                ECO:0000269|PubMed:12430021,
FT                                ECO:0000269|PubMed:13129913,
FT                                ECO:0000269|PubMed:15736934,
FT                                ECO:0000269|PubMed:16225867,
FT                                ECO:0000269|PubMed:17855366,
FT                                ECO:0000269|PubMed:17958399,
FT                                ECO:0000269|PubMed:19211556}.
FT   BINDING     344    344       Phosphoenolpyruvate. {ECO:0000255|HAMAP-
FT                                Rule:MF_00210,
FT                                ECO:0000269|PubMed:11171958,
FT                                ECO:0000269|PubMed:16225867,
FT                                ECO:0000269|PubMed:17855366,
FT                                ECO:0000269|PubMed:19211556}.
FT   BINDING     386    386       Phosphoenolpyruvate. {ECO:0000255|HAMAP-
FT                                Rule:MF_00210,
FT                                ECO:0000269|PubMed:11171958,
FT                                ECO:0000269|PubMed:16225867,
FT                                ECO:0000269|PubMed:17855366,
FT                                ECO:0000269|PubMed:19211556}.
FT   BINDING     411    411       Phosphoenolpyruvate. {ECO:0000255|HAMAP-
FT                                Rule:MF_00210,
FT                                ECO:0000269|PubMed:11171958,
FT                                ECO:0000269|PubMed:16225867,
FT                                ECO:0000269|PubMed:17855366,
FT                                ECO:0000269|PubMed:19211556}.
FT   SITE        408    408       Modified by bromopyruvate.
FT                                {ECO:0000269|PubMed:11171958}.
FT   SITE        411    411       Modified by bromopyruvate.
FT                                {ECO:0000269|PubMed:11171958}.
FT   MUTAGEN      96     96       G->A: Insensitive to glyphosate with
FT                                unaltered affinity for its first
FT                                substrate S3P, but displays a 30-fold
FT                                lower affinity for its second substrate
FT                                PEP. {ECO:0000269|PubMed:12430021}.
FT   MUTAGEN      97     97       T->I: This mutant is sensitive to
FT                                glyphosate and causes a substantial
FT                                decrease in the affinity for PEP.
FT                                Insensitive to glyphosate but maintains
FT                                high affinity for PEP. It causes a shift
FT                                of residue G96 toward the glyphosate
FT                                binding site, impairing efficient binding
FT                                of glyphosate, while the side chain of
FT                                I97 points away from the substrate
FT                                binding site, facilitating PEP
FT                                utilization; when associated with S-101.
FT                                {ECO:0000269|PubMed:19211556}.
FT   MUTAGEN     101    101       P->A: Displays a slight decrease of the
FT                                affinity binding for both S3P and PEP.
FT                                Decreases the binding affinity of
FT                                glyphosate, reducing the potency of this
FT                                inhibitor. {ECO:0000269|PubMed:17855366,
FT                                ECO:0000269|PubMed:19211556}.
FT   MUTAGEN     101    101       P->G: Displays a slight decrease of the
FT                                affinity binding for both S3P and PEP.
FT                                Decreases the binding affinity of
FT                                glyphosate, reducing the potency of this
FT                                inhibitor. {ECO:0000269|PubMed:17855366,
FT                                ECO:0000269|PubMed:19211556}.
FT   MUTAGEN     101    101       P->L: Displays a 2-fold lower affinity
FT                                binding for both S3P and PEP. Decreases
FT                                the binding affinity of glyphosate,
FT                                reducing the potency of this inhibitor.
FT                                {ECO:0000269|PubMed:17855366,
FT                                ECO:0000269|PubMed:19211556}.
FT   MUTAGEN     101    101       P->S: Displays a slight decrease of the
FT                                affinity binding for both S3P and PEP.
FT                                Decreases the binding affinity of
FT                                glyphosate, reducing the potency of this
FT                                inhibitor. Insensitive to glyphosate but
FT                                maintains high affinity for PEP. It
FT                                causes a shift of residue G96 toward the
FT                                glyphosate binding site, impairing
FT                                efficient binding of glyphosate, while
FT                                the side chain of I97 points away from
FT                                the substrate-binding site, facilitating
FT                                PEP utilization; when associated with I-
FT                                97. {ECO:0000269|PubMed:17855366,
FT                                ECO:0000269|PubMed:19211556}.
FT   MUTAGEN     313    313       D->A: The enolpyruvyl transfer reaction
FT                                is halted after formation of the
FT                                tetrahedral adduct of the substrates.
FT                                {ECO:0000269|PubMed:13129913}.
FT   CONFLICT     23     23       S -> T (in Ref. 1; CAA25223).
FT                                {ECO:0000305}.
FT   CONFLICT    330    330       T -> R (in Ref. 1; CAA25223).
FT                                {ECO:0000305}.
FT   STRAND        3      6       {ECO:0000244|PDB:1G6S}.
FT   STRAND       11     17       {ECO:0000244|PDB:1G6S}.
FT   HELIX        22     34       {ECO:0000244|PDB:1G6S}.
FT   STRAND       35     43       {ECO:0000244|PDB:1G6S}.
FT   HELIX        48     59       {ECO:0000244|PDB:1G6S}.
FT   STRAND       63     66       {ECO:0000244|PDB:1G6S}.
FT   STRAND       68     70       {ECO:0000244|PDB:1P88}.
FT   STRAND       73     76       {ECO:0000244|PDB:1G6S}.
FT   STRAND       79     81       {ECO:0000244|PDB:1P88}.
FT   STRAND       88     91       {ECO:0000244|PDB:1G6S}.
FT   HELIX        96    105       {ECO:0000244|PDB:1G6S}.
FT   STRAND      108    116       {ECO:0000244|PDB:1G6S}.
FT   HELIX       119    123       {ECO:0000244|PDB:1G6S}.
FT   HELIX       127    135       {ECO:0000244|PDB:1G6S}.
FT   STRAND      140    145       {ECO:0000244|PDB:1G6S}.
FT   STRAND      151    155       {ECO:0000244|PDB:1G6S}.
FT   STRAND      160    168       {ECO:0000244|PDB:1G6S}.
FT   HELIX       171    179       {ECO:0000244|PDB:1G6S}.
FT   HELIX       180    182       {ECO:0000244|PDB:1G6S}.
FT   STRAND      183    185       {ECO:0000244|PDB:1G6S}.
FT   STRAND      187    195       {ECO:0000244|PDB:1G6S}.
FT   HELIX       199    210       {ECO:0000244|PDB:1G6S}.
FT   STRAND      216    218       {ECO:0000244|PDB:1G6S}.
FT   TURN        219    221       {ECO:0000244|PDB:1G6S}.
FT   STRAND      222    225       {ECO:0000244|PDB:1G6S}.
FT   STRAND      235    238       {ECO:0000244|PDB:1G6S}.
FT   HELIX       243    256       {ECO:0000244|PDB:1G6S}.
FT   STRAND      257    264       {ECO:0000244|PDB:1G6S}.
FT   HELIX       272    275       {ECO:0000244|PDB:1G6S}.
FT   HELIX       276    283       {ECO:0000244|PDB:1G6S}.
FT   STRAND      286    289       {ECO:0000244|PDB:1G6S}.
FT   STRAND      291    297       {ECO:0000244|PDB:1G6S}.
FT   STRAND      305    307       {ECO:0000244|PDB:1G6S}.
FT   TURN        312    314       {ECO:0000244|PDB:1G6S}.
FT   HELIX       315    321       {ECO:0000244|PDB:1G6S}.
FT   HELIX       322    324       {ECO:0000244|PDB:1G6S}.
FT   STRAND      325    327       {ECO:0000244|PDB:1G6S}.
FT   STRAND      329    333       {ECO:0000244|PDB:1G6S}.
FT   HELIX       335    339       {ECO:0000244|PDB:1G6S}.
FT   STRAND      340    342       {ECO:0000244|PDB:1G6S}.
FT   HELIX       344    354       {ECO:0000244|PDB:1G6S}.
FT   STRAND      358    361       {ECO:0000244|PDB:1G6S}.
FT   STRAND      363    369       {ECO:0000244|PDB:1G6S}.
FT   HELIX       385    392       {ECO:0000244|PDB:1G6S}.
FT   HELIX       393    395       {ECO:0000244|PDB:1G6S}.
FT   STRAND      396    399       {ECO:0000244|PDB:1G6S}.
FT   STRAND      401    405       {ECO:0000244|PDB:1G6S}.
FT   HELIX       406    411       {ECO:0000244|PDB:1G6S}.
FT   HELIX       416    423       {ECO:0000244|PDB:1G6S}.
SQ   SEQUENCE   427 AA;  46096 MW;  B1F55469EB4D9F97 CRC64;
     MESLTLQPIA RVDGTINLPG SKSVSNRALL LAALAHGKTV LTNLLDSDDV RHMLNALTAL
     GVSYTLSADR TRCEIIGNGG PLHAEGALEL FLGNAGTAMR PLAAALCLGS NDIVLTGEPR
     MKERPIGHLV DALRLGGAKI TYLEQENYPP LRLQGGFTGG NVDVDGSVSS QFLTALLMTA
     PLAPEDTVIR IKGDLVSKPY IDITLNLMKT FGVEIENQHY QQFVVKGGQS YQSPGTYLVE
     GDASSASYFL AAAAIKGGTV KVTGIGRNSM QGDIRFADVL EKMGATICWG DDYISCTRGE
     LNAIDMDMNH IPDAAMTIAT AALFAKGTTT LRNIYNWRVK ETDRLFAMAT ELRKVGAEVE
     EGHDYIRITP PEKLNFAEIA TYNDHRMAMC FSLVALSDTP VTILDPKCTA KTFPDYFEQL
     ARISQAA
//
